Company Filing History:
1 out of 528 
1 out of 654 
Years Active: 2024
Title: Innovator David Cognetti: Advancing Cancer Treatment with Patented Technology
Introduction: David Cognetti, an accomplished inventor based in Penn Valley, Pennsylvania, has made significant contributions in the field of medical technology. With a focus on improving cancer treatment, he holds a patent for a novel device aimed at enhancing patient outcomes. Cognetti's innovation represents a merging of biocompatibility and advanced therapeutic techniques in oncology.
Latest Patents: Cognetti's notable patent, titled "Tumor Bed Implant for Multimodality Treatment of At-Risk Tissue Surrounding a Resection Cavity," details a device designed for surgical placement within a resection cavity. The implant utilizes a biocompatible polymer body integrated with regularly spaced radiation seeds and magnetic materials. This innovative design allows for localized hyperthermia combined with radiation and potentially, chemotherapy and immunotherapy, which are released gradually from the polymer. This technology aims to effectively treat at-risk tissue within tumor margins, potentially improving survival rates and reducing recurrence.
Career Highlights: With a strong academic background, David Cognetti has contributed to the medical field through work at esteemed institutions, including Thomas Jefferson University and Drexel University. His research has focused on translating innovative concepts into practical medical solutions, particularly in the realm of cancer treatment.
Collaborations: Throughout his career, Cognetti has collaborated with esteemed professionals in the field, such as Paul Stauffer and Voichita Bar-Ad. These partnerships have further enhanced his research and development endeavors, fostering an environment of innovation and advancement in medical technology.
Conclusion: David Cognetti stands out as a visionary inventor dedicated to revolutionizing cancer treatment. His patented technology reflects a commitment to improving patient care through innovative solutions. With continued collaboration and research, Cognetti’s contributions are likely to make a lasting impact on medical practices and patient outcomes in oncology.